Live feed18:05:00·1249dPRReleasevia QuantisnowAchilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022ByQuantisnow·Wall Street's wire, on your screen.ACHL· Achilles Therapeutics plcHealth Care
